Ex parte HANSON et al. - Page 34




          Appeal No. 94-3255                                                          
          Application 07/673,264                                                      


               growth at 50 C in nutrient media comprisingO                                                          
               methanol as a source of carbon and energy and                          
               vitamin B  and excreting at least about 5 g/l                          
                        12                                                            
               of lysine, aspartic acid, phenylalanine, or                            
               tryptophan when grown on a media containing a                          
               nitrogen source.                                                       
                                     Discussion                                       
               The examiner has intermingled her arguments with respect               
          to the requirements of the 35 U.S.C. § 112, first and second                
          paragraphs.  Appellants have similarly responded.                           
          Consequently, the issues to be considered to determine                      
          compliance with the requirements of each paragraph and the                  
          factual findings pertinent to each issue are out of focus.  I               
          shall try to delineate the issues and apply the facts as they               
          relate to the requirements of either the first or the second                
          paragraph of 35 U.S.C. § 112.                                               
               Under the second paragraph of section 112, the claim must              
          particularly point out and distinctly claim the subject matter              
          applicants regard as their invention.  The examiner argues                  
          that certain terms utilized to define “[a]n amino acid                      
          producing auxotrophic bacterium of a biologically pure strain               
          ribulose monophosphate pathway-utilizing bacterium Bacillus                 
          MGA3, or biologically pure strain corresponding environmental               

                                          5                                           





Page:  Previous  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  Next 

Last modified: November 3, 2007